Character based search and discovery of media content
US-2025280177-A1 · Sep 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
Chan Timothy patents
Chan Timothy is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Chan Timothy |
| Total patents | 29 |
| First publication | Oct 1, 2015 |
| Latest publication | Sep 4, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Character based search and discovery of media content
US-12316919-B2 · May 27, 2025 · US
Character based search and discovery of media content
US-2024348889-A1 · Oct 17, 2024 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2024294524-A1 · Sep 5, 2024 · US
Methods for predicting immune checkpoint blockade efficacy across multiple cancer types
US-2024282410-A1 · Aug 22, 2024 · US
Character based search and discovery of media content
US-12047655-B2 · Jul 23, 2024 · US
Relevance-based search and discovery of media content
US-11979641-B2 · May 7, 2024 · US
Relevance-based search and discovery of media content
US-2023126519-A1 · Apr 27, 2023 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2023113598-A1 · Apr 13, 2023 · US
IRAK4 inhibiting agents
US-11427561-B2 · Aug 30, 2022 · US
Recent patents
Latest publications not already listed above.
Character based search and discovery of media content
US-2021266642-A1 · Aug 26, 2021 · US
Irak4 inhibiting agents
US-2021188809-A1 · Jun 24, 2021 · US
Character based search and discovery of media content
US-10812863-B2 · Oct 20, 2020 · US
IRAK4 inhibiting agents
US-10577367-B2 · Mar 3, 2020 · US
Irak4 inhibiting agents
US-2019248787-A1 · Aug 15, 2019 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2019119268-A1 · Apr 25, 2019 · US
IRAK4 inhibiting agents
US-10246456-B2 · Apr 2, 2019 · US
Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12
US-2019062394-A1 · Feb 28, 2019 · US
Heterocyclic compounds useful as PDK1 inhibitors
US-10030016-B2 · Jul 24, 2018 · US
S1P and/or ATX modulating agents
US-9850206-B2 · Dec 26, 2017 · US
S1P and/or ATX modulating agents
US-9771326-B2 · Sep 26, 2017 · US
Irak4 inhibiting agents
US-2017204093-A1 · Jul 20, 2017 · US
Character based search and discovery of media content
US-2017094365-A1 · Mar 30, 2017 · US
Character based search and discovery of media content
US-9552124-B2 · Jan 24, 2017 · US
Heterocyclic compounds useful as PDK1 inhibitors
US-9546165-B2 · Jan 17, 2017 · US
Heterocyclic compounds useful as pdk1 inhibitors
US-2016331756-A1 · Nov 17, 2016 · US
Determinants of cancer response to immunotherapy
US-2016326597-A1 · Nov 10, 2016 · US
S1p and/or atx modulating agents
US-2015299123-A1 · Oct 22, 2015 · US
S1p and/or atx modulating agents
US-2015274663-A1 · Oct 1, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Biogen Ma Inc | 8 |
| Millennium Pharm Inc | 6 |
| Tivo Corp | 5 |
| Sunesis Pharmaceuticals Inc | 4 |
| Mobitv Inc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/14 | 12 |
| C07D401/12 | 12 |
| A61P35/00 | 10 |
| G06F16/5846 | 10 |
| G06F3/048 | 10 |